• Armata Pharmaceuticals promoted David House to chief financial officer as it prepares to advance AP-SA02 into Phase 3.
• House previously served as senior vice president, finance, principal financial officer since August 2024.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Armata Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA07591) on July 20, 2026, and is solely responsible for the information contained therein.